United-Guardian (NASDAQ:UG) Coverage Initiated at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of United-Guardian (NASDAQ:UG) in a research note issued to investors on Saturday. The firm set a “buy” rating on the stock.

United-Guardian Price Performance

UG opened at $8.01 on Friday. United-Guardian has a 12 month low of $5.79 and a 12 month high of $10.25. The stock has a market capitalization of $36.77 million, a price-to-earnings ratio of 14.30 and a beta of 0.73. The business has a fifty day moving average price of $7.99 and a 200 day moving average price of $7.67.

United-Guardian (NASDAQ:UG) last released its quarterly earnings data on Friday, March 22nd. The company reported $0.16 earnings per share (EPS) for the quarter. The business had revenue of $2.61 million during the quarter. United-Guardian had a return on equity of 24.26% and a net margin of 23.71%.

Institutional Trading of United-Guardian

A number of large investors have recently made changes to their positions in UG. Wells Fargo & Company MN raised its stake in United-Guardian by 277.1% during the 2nd quarter. Wells Fargo & Company MN now owns 4,521 shares of the company’s stock valued at $37,000 after acquiring an additional 3,322 shares during the last quarter. Citadel Advisors LLC raised its stake in United-Guardian by 55.4% during the 2nd quarter. Citadel Advisors LLC now owns 15,694 shares of the company’s stock valued at $134,000 after acquiring an additional 5,596 shares during the last quarter. Northern Trust Corp purchased a new stake in United-Guardian during the 4th quarter valued at approximately $151,000. UBS Group AG raised its stake in United-Guardian by 39.3% during the 1st quarter. UBS Group AG now owns 25,834 shares of the company’s stock valued at $243,000 after acquiring an additional 7,289 shares during the last quarter. Finally, Vanguard Group Inc. raised its stake in United-Guardian by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 133,245 shares of the company’s stock valued at $959,000 after acquiring an additional 1,949 shares during the last quarter. 23.16% of the stock is owned by institutional investors and hedge funds.

United-Guardian Company Profile

United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.